CUSIP: 74319F107
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
6,845,756
-
Total 13F shares
-
55,044,619
-
Share change
-
+11,843,702
-
Total reported value
-
$196,475,000
-
Put/Call ratio
-
95%
-
Price per share
-
$3.57
-
Number of holders
-
42
-
Value change
-
+$37,889,508
-
Number of buys
-
26
-
Number of sells
-
32
Quarterly Holders Quick Answers
What is CUSIP 74319F107?
CUSIP 74319F107 identifies BIOR - Biora Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 74319F107:
Institutional Holders of Biora Therapeutics, Inc. - Common Stock, par value $0.001 per share (BIOR) as of Q2 2021
As of 30 Jun 2021,
Biora Therapeutics, Inc. - Common Stock, par value $0.001 per share (BIOR) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,044,619 shares.
The largest 10 holders included
Athyrium Capital Management, LP, ARMISTICE CAPITAL, LLC, Neuberger Berman Group LLC, Parian Global Management LP, VANGUARD GROUP INC, BlackRock Inc., Birchview Capital, LP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.